Short description
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Description
ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space.
ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
Last funding
Cannot Access
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Munich, Bayern, Germany, Europe
Founded on
January 1, 2018
Exited on
June 17, 2021
Went public on
June 17, 2021
Stock symbol
ATAI
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Noaccessforu, Uh Ohhhh, Noaccess, No Way, Noway Youcantaccess, Noaccessforu, Noaccessforu, Absolutely Noaccess, Noaccessforu, No Way, Noway Youcantaccess, Absolutely Noaccess, Noaccessforu, Cannot Access, Noaccess, Uh Ohhhh, Noaccess, No Way, Uh Ohhhh, Nopepepe, Noway Youcantaccess, No Way, Noway Youcantaccess, Noaccess, No Way, Cannot Access, Nopepepe, Noway Youcantaccess, Noaccess, Uh Ohhhh, Noaccessforu, Noaccessforu, Cannot Access, Noaccess, Cannot Access, Noway Youcantaccess, Cannot Access, Uh Ohhhh, Uh Ohhhh, Noaccess, Nopepepe
Sign in for full access
Founders
Christian Angermayer, Florian Brand, Lars Christian Wilde, Srinivas Rao
Funding rounds count
9
Portfolio organisations count
Noway Youcantaccess, Nopepepe
Sign in for full access
Lead investments count
7
Exits count
Noaccess, Noaccess
Sign in for full access
IPO exits count
2